BiotechTube
Home/Merlin Biotech/Ian Henrich, PhD
IH

Ian Henrich, PhD

Vice President, Research and Development

Merlin Biotech

Therapeutic Areas

OncologyInfectious Disease

Merlin Biotech Pipeline

DrugIndicationPhase
MER-101Adult Solid Cancers; Pediatric Sarcomas (e.g., Ewing Sarcoma)Pre-clinical

Leadership Team at Merlin Biotech

RN
Randall N. Hyer, MD, PhD, MPH
Chief Executive Officer
NS
Nick Spring, DipM, MCIM
Business Strategy & Commercialization
YS
Yolanda Sanchez, PhD, MS
Clinical Study Design & Drug Development
View full Merlin Biotech profile